Burkert opens manufacturing facility in Pune to increase local production

By Staff Report October 17, 2024 11:31 am IST

Burkert Fluid Control Systems India Private Limited has opened a new manufacturing facility in Pune, Maharashtra, to meet growing demand in the region.

Burkert Fluid Control Systems India Private Limited, a leading manufacturer of measurement and control systems for liquids and gases, inaugurated its new manufacturing facility in Pune, Maharashtra, with a ceremony. This state-of-the-art facility is an addition to Burkert’s global value chain, aimed at meeting the growing demand in the region by producing components and system solutions.

The new facility in Talegaon MIDC, Phase 2, spans 50,000 square feet and features advanced machining, assembly, and testing centres for optimal productivity. It has the capacity to produce over 30,000 valves and 500 systems annually. This new unit brings production closer to Burkert’s customers, boosting local employment and enhancing service delivery. Initially, the Talegaon facility will focus on manufacturing mass flow controllers, angle seat valves, diaphragm valves, and system solutions, with plans to expand production in phases to meet the diverse needs of Indian industries.

Georg Stawowy, CEO of Bürkert Fluid Control Systems, said, “The opening of our new manufacturing facility in India is a testament to our commitment to the Indian market and the government’s ‘Make in India’ vision. By manufacturing locally, we can better serve our customers with customised products and systems that meet their specific needs. Our goal is to make Burkert an integral part of India’s industrial landscape by combining our global expertise with local production capabilities.”

Advertising

Your future advertising space? Our media data

The Talegaon unit is expected to employ up to 32 people by the end of this year, with the potential to grow to 100 employees next year. Burkert’s technology transfer to India has already been completed for several unique systems, including panels for Zone 1 ATEX classification. This local production will play a pivotal role in Burkert’s long-term profitability goals, with the company expecting the facility to be profitable by 2028.

Burkert, a global company with a turnover of 710 million EUR, employs over 3,700 people and heavily invests in R&D, accounting for 6.9% of its revenue. Its significant clients in India include Zydus, Alembic, Sun Pharma, Biocon, Bharat Biotech, and Serum Institute.